MedTrace Logo

Ultrasound Detection and Characterization of Subclinical Hypertrophy in Diabetes

NCT02348099 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-05-07

Study results available
· View outcomes & findings →

Summary

This is a pilot study to enroll 100 people to assess the incidence of lipohypertrophy as detected with ultrasound and its impact on glycemic variability.

Conditions

Interventions

OTHER

Ultrasound

Abdomen scanned with portable ultrasound to determine presence of subclinical lipohypertrophy.

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Graydon Meneilly, MD · University of British Columbia

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2021-02-08
Completion
2025-04-22

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02348099 on ClinicalTrials.gov